Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011386
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical support, manufacturing support and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to global pharmaceutical companies, biotechnology companies, government agencies, as well as leading hospitals and academic institutions, and operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc (CRL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Laboratories International Inc, Medical Equipment, Deal Details 12
Partnerships 12
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson’s Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
Asset Transactions 23
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Acquisition 24
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc – Key Competitors 26
Charles River Laboratories International Inc – Key Employees 27
Charles River Laboratories International Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 33
Financial Announcements 33
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 33
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 35
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 37
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 39
Nov 02, 2016: Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations 42
Aug 03, 2016: Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations 44
May 04, 2016: Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations 46
Feb 10, 2016: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance 48
Corporate Communications 51
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 51
Product News 52
Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017 52
Other Significant Developments 54
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 54
Jun 28, 2017: SenzaGen signs global distribution agreement with Charles River Laboratories 55
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 56
Sep 29, 2016: PathoQuest Announces Partnership with Charles River Laboratories 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2016 2
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc, Key Competitors 26
Charles River Laboratories International Inc, Key Employees 27
Charles River Laboratories International Inc, Subsidiaries 29

★海外企業調査レポート[Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company that manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, insulin, injection, creams and gels, and solution …
  • Bitauto Holdings Limited:企業のM&A・事業提携・投資動向
    Bitauto Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bitauto Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Tufts Medical Center:医療機器:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Poudre Valley Rural Electric Association, Inc.:企業の戦略的SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • AECOM :企業の戦略・SWOT・財務情報
    AECOM - Strategy, SWOT and Corporate Finance Report Summary AECOM - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Mega Lifesciences Public Co Ltd (MEGA):企業の財務・戦略的SWOT分析
    Summary Mega Lifesciences Public Co Ltd (Mega) is a manufacturer, marketer and distributor of pharmaceutical and nutraceutical products. The company provides product categories such as complimentary medicines, OTC medicines, prescription medicines, and others. It offers complimentary medicines such …
  • EndoChoice Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoChoice Inc (EndoChoice), a subsidiary of Boston Scientific Corp is a medical device company that develops and commercializes medical devices, diagnostic equipment, infection control products and endoscopic imaging systems. The company’s infection control products comprise biopsy valves, …
  • TFS International AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TFS International AB (TFS International) is a contract research organization that provides clinical development solutions. The organization through its business areas, TFS Develop and TFS People, provides various services worldwide including clinical development planning, regulatory affairs, …
  • Alamos Gold Inc:企業の戦略・SWOT・財務分析
    Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Soligenix Inc (SNGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Flex Pharma Inc (FLKS):製薬・医療:M&Aディール及び事業提携情報
    Summary Flex Pharma Inc (Flex Pharma) is a clinical-stage biotechnology company that offers discovery and development of innovative and proprietary treatments for muscle cramps, spasms and spasticity connected to the severe neurological diseases of ALS, MS, fibromyalgia, hypomagnesemia, hypocalcemia …
  • Arab International Bank:企業の戦略・SWOT・財務情報
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bata India Limited:戦略・SWOT・企業財務分析
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務情報
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vaxart Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaxart Inc (Vaxart) focuses on the development of recombinant vaccines based on its proprietary oral vaccine delivery platform. The company is currently developing tablet vaccines for seasonal and pandemic influenza, norovirus, and Respiratory Syncytial Virus (RSV). Vaxart’s vaccine delivery …
  • Meridian Energy Ltd (MEL):電力:M&Aディール及び事業提携情報
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆